Allyx Therapeutics

555 Long Wharf Drive
Floor 11
New Haven, Connecticut 06511

Phone: 908-432-2845
Website: https://www.allyxthera.com

General Information:

Allyx Therapeutics is a clinical stage biotech company focused on developing a novel oral drug therapy for Alzheimer’s disease and other neurodegenerative diseases. Our lead drug program ALX-001 (BMS-984923) offers a promising approach to protect and restore dysfunctional and lost synapses in the brain. Allyx is currently launching a Phase 2 clinical trial to provide clinical proof of concept in Alzheimer’s disease patients.